This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kawada, S.-z. Articles by Nakano, H. Search for Related Content PubMed PubMed Citation Articles by Kawada, S.-z. Articles by Nakano, H.

Induction of a Heat-stable Topoisomerase II-DNA Cleavable Complex by Nonintercalative Terpenoides, Terpentecin and Clerocidin

Tokyo Research Laboratories, Kyowa Hakko Co., Ltd., 3-6-6 Asahimachi, Machida, Tokyo 194, Japan

Terpentecin and clerocidin, microbial terpenoides, have been known to be potent antitumor antibiotics. However, the critical biochemical target of these terpenoides has not been identified. Our present studies, using purified mammalian topoisomerase II, have shown that terpentecin and clerocidin induce topoisomerase II-mediated DNA cleavage in vitro with comparable potency to that of demethylepipodophyllotoxin ethylidene-ß-D-glucoside. These terpenoides produced a similar DNA cleavage pattern which is distinctly different from those generated in the presence of the known topoisomerase poisons, demethylepipodophyllotoxin ethylidene-ß-D-glucoside and 4'-(9-acridinylamino)methanesulfon-m-anisidide. Brief heating at 65°C, which abolishes completely the cleavable complex with demethylepipodophyllotoxin ethylidene-ß-D-glucoside, of the reaction mixture containing these terpenoides resulted in slight reduction in DNA cleavage. Thus, differently from other topoisomerase II-active antitumor agents, terpentecin and clerocidin induce formation of a cleavable complex which is stable for heat or salt treatments. The lack of significant DNA binding or intercalation activity of terpentecin and clerocidin suggests that topoisomerase II is a cellular target for these drugs.

¹ To whom requests for reprints should be addressed.

Received 9/13/90. Accepted 3/25/91.

This article has been cited by other articles:

				X. S. Pan, M. Dias, M. Palumbo, and L. M. Fisher Clerocidin selectively modifies the gyrase-DNA gate to induce irreversible and reversible DNA damage Nucleic Acids Res., October 1, 2008; 36(17): 5516 - 5529. [Abstract] [Full Text] [PDF]

				M. Malik, K. C. Nitiss, V. Enriquez-Rios, and J. L. Nitiss Roles of nonhomologous end-joining pathways in surviving topoisomerase II-mediated DNA damage. Mol. Cancer Ther., June 1, 2006; 5(6): 1405 - 1414. [Abstract] [Full Text] [PDF]

				S. N. Richter, E. Leo, G. Giaretta, B. Gatto, L. M. Fisher, and M. Palumbo Clerocidin interacts with the cleavage complex of Streptococcus pneumoniae topoisomerase IV to induce selective irreversible DNA damage Nucleic Acids Res., April 13, 2006; 34(7): 1982 - 1991. [Abstract] [Full Text] [PDF]

				S. N. Richter, I. Menegazzo, D. Fabris, and M. Palumbo Concerted bis-alkylating reactivity of clerocidin towards unpaired cytosine residues in DNA Nucleic Acids Res., October 19, 2004; 32(18): 5658 - 5667. [Abstract] [Full Text] [PDF]

				S. Richter, B. Gatto, D. Fabris, K.-i. Takao, S. Kobayashi, and M. Palumbo Clerocidin alkylates DNA through its epoxide function: evidence for a fine tuned mechanism of action Nucleic Acids Res., September 1, 2003; 31(17): 5149 - 5156. [Abstract] [Full Text] [PDF]

				B. Gatto, S. Richter, S. Moro, G. Capranico, and M. Palumbo The topoisomerase II poison clerocidin alkylates non-paired guanines of DNA: implications for irreversible stimulation of DNA cleavage Nucleic Acids Res., October 15, 2001; 29(20): 4224 - 4230. [Abstract] [Full Text] [PDF]

				D. Strumberg, J. L. Nitiss, J. Dong, K. W. Kohn, and Y. Pommier Molecular Analysis of Yeast and Human Type II Topoisomerases. ENZYME-DNA AND DRUG INTERACTIONS J. Biol. Chem., October 1, 1999; 274(40): 28246 - 28255. [Abstract] [Full Text] [PDF]

				N. Fujii, Y. Yamashita, T. Mizukami, and H. Nakano Correlation between the Formation of Cleavable Complex with Topoisomerase I and Growth-Inhibitory Activity for Saintopin-Type Antibiotics Mol. Pharmacol., February 1, 1997; 51(2): 269 - 276. [Abstract] [Full Text] [PDF]

				Y. Hsiung, S. H. Elsea, N. Osheroff, and J. L. Nitiss A Mutation in Yeast TOP2 Homologous to a Quinolone-resistant Mutation in Bacteria J. Biol. Chem., September 1, 1995; 270(35): 20359 - 20364. [Abstract] [Full Text] [PDF]